Howard Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,615
Closed -$202K 118
2024
Q4
$202K Sell
7,615
-417
-5% -$11.3K 0.11% 114
2024
Q3
$232K Sell
8,032
-148
-2% -$4.32K 0.14% 106
2024
Q2
$229K Sell
8,180
-1,396
-15% -$38.4K 0.18% 90
2024
Q1
$266K Sell
9,576
-2,650
-22% -$73.5K 0.22% 85
2023
Q4
$352K Sell
12,226
-457
-4% -$13.8K 0.29% 67
2023
Q3
$421K Buy
12,683
+1,615
+15% +$57.1K 0.39% 57
2023
Q2
$406K Sell
11,068
-250
-2% -$9.73K 0.35% 62
2023
Q1
$462K Hold
11,318
0.39% 61
2022
Q4
$580K Buy
11,318
+85
+0.8% +$4.08K 0.48% 56
2022
Q3
$491K Buy
11,233
+6,540
+139% +$318K 0.35% 63
2022
Q2
$246K Sell
4,693
-6,926
-60% -$353K 0.26% 53
2022
Q1
$601K Sell
11,619
-46
-0.4% -$2.39K 0.33% 65
2021
Q4
$688K Buy
11,665
+43
+0.4% +$2.13K 0.36% 65
2021
Q3
$499K Sell
11,622
-231
-2% -$10.2K 0.28% 81
2021
Q2
$464K Buy
11,853
+918
+8% +$35.7K 0.26% 82
2021
Q1
$396K Sell
10,935
-649
-6% -$23K 0.23% 88
2020
Q4
$426K Sell
11,584
-788
-6% -$28.9K 0.27% 83
2020
Q3
$430K Buy
12,372
+287
+2% +$10.1K 0.31% 73
2020
Q2
$374K Buy
12,085
+107
+0.9% +$3.63K 0.31% 76
2020
Q1
$370K Sell
11,978
-205
-2% -$6.99K 0.39% 65
2019
Q4
$452K Buy
+12,183
New +$434K 0.38% 65

Other funds holding PFE

Howard Wealth Management's PFE Position: Q1 2025 in Review

Howard Wealth Management sold out of Pfizer (PFE) in Q1 2025, closing a stake of 7,615 shares — an estimated $202K sold.

Howard Wealth Management first reported a position in PFE in Q4 2019 and held it in 21 quarters. The position peaked at $688K in Q4 2021. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Howard Wealth Management reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Howard Wealth Management sold 7,615 Pfizer shares in Q1 2025, an estimated $202K.
  • Howard Wealth Management first reported a position in Pfizer in Q4 2019 and held it in 21 quarters.
  • Howard Wealth Management's Pfizer position peaked at $688K in Q4 2021.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Howard Wealth Management's 13F filing for Q1 2025, filed 13 May 2025.